PT99435A - Processo para a preparacao de derivados de amino-sulfonil-ureia e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de derivados de amino-sulfonil-ureia e de composicoes farmaceuticas que os contem

Info

Publication number
PT99435A
PT99435A PT99435A PT9943591A PT99435A PT 99435 A PT99435 A PT 99435A PT 99435 A PT99435 A PT 99435A PT 9943591 A PT9943591 A PT 9943591A PT 99435 A PT99435 A PT 99435A
Authority
PT
Portugal
Prior art keywords
pharmaceutical compositions
sulfonyl
amino
preparation
compositions containing
Prior art date
Application number
PT99435A
Other languages
English (en)
Other versions
PT99435B (pt
Inventor
Drago Robert Sliskovic
Joseph Armand Picard
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PT99435A publication Critical patent/PT99435A/pt
Publication of PT99435B publication Critical patent/PT99435B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04Diamides of sulfuric acids
    • C07C307/06Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04Diamides of sulfuric acids
    • C07C307/08Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04Diamides of sulfuric acids
    • C07C307/10Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT99435A 1990-11-07 1991-11-06 Processo para a preparacao de derivados de amino-sulfonil-ureia e de composicoes farmaceuticas que os contem PT99435B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61028790A 1990-11-07 1990-11-07
US07/747,040 US5214206A (en) 1990-11-07 1991-08-19 Aminosulfonyl urea acat inhibitors

Publications (2)

Publication Number Publication Date
PT99435A true PT99435A (pt) 1992-12-31
PT99435B PT99435B (pt) 1999-04-30

Family

ID=27086230

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99435A PT99435B (pt) 1990-11-07 1991-11-06 Processo para a preparacao de derivados de amino-sulfonil-ureia e de composicoes farmaceuticas que os contem

Country Status (16)

Country Link
US (2) US5214206A (pt)
EP (1) EP0556322B1 (pt)
JP (2) JP3256541B2 (pt)
AT (1) ATE139226T1 (pt)
AU (1) AU657928B2 (pt)
CA (1) CA2094806C (pt)
DE (1) DE69120287T2 (pt)
DK (1) DK0556322T3 (pt)
ES (1) ES2088128T3 (pt)
GR (1) GR3020355T3 (pt)
IE (1) IE75379B1 (pt)
MX (1) MX9101958A (pt)
NZ (1) NZ240481A (pt)
PH (1) PH30665A (pt)
PT (1) PT99435B (pt)
WO (1) WO1992008694A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012144A1 (en) * 1990-12-28 1992-07-23 Teijin Limited Condensed benzoxa ring compound, production thereof, and pharmaceutical composition containing the same
US5576335A (en) * 1994-02-01 1996-11-19 Nisshin Flour Milling Co., Ltd. Urea derivatives and their use as ACAT inhibitors
US5491170A (en) * 1994-12-19 1996-02-13 Warner-Lambert Company β-carboxy sulfonamide ACAT inhibitors
US6103733A (en) * 1998-09-09 2000-08-15 Bachmann; Kenneth A. Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes
CA2369967A1 (en) * 2001-02-12 2002-08-12 Joseph Anthony Cornicelli Methods of treating nuclear factor-kappa b mediated diseases and disorders
EP1281399A3 (en) * 2001-08-01 2004-02-11 Warner-Lambert Company Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
EP2640721B1 (en) * 2010-11-16 2018-06-06 Texas Heart Institute Agonists that enhance binding of integrin-expressing cells to integrin receptors
CN103288749A (zh) * 2013-03-04 2013-09-11 盐城工学院 可作除草剂的氨基磺酰脲类化合物
WO2016053107A1 (en) * 2014-10-03 2016-04-07 Synaffix B.V. Sulfamide linker, conjugates thereof, and methods of preparation
MY193765A (en) * 2015-02-16 2022-10-27 Univ Queensland Sulfonylureas and related compounds and use of same
US11858922B2 (en) * 2016-02-16 2024-01-02 The University Of Queensland Sulfonylureas and related compounds and use of same
HRP20220195T1 (hr) 2017-07-07 2022-04-15 Inflazome Limited Novi spojevi sulfonamid karboksamida
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
PE20211333A1 (es) 2018-08-15 2021-07-22 Inflazome Ltd Compuestos de sulfonamidaurea novedosos
SMT202400291T1 (it) 2019-06-12 2024-09-16 Nodthera Ltd The Mansion Derivati di solfonilurea e loro usi

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2312404A (en) * 1939-11-22 1943-03-02 Haack Erich Method of preparing n-sulphonylureas
CH396872A (de) 1959-08-13 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Harnstoffe
US3242174A (en) * 1962-02-06 1966-03-22 Pfizer & Co C 1-(tertiary aminosulfonyl)-3-(hydrocarbon) ureas
GB990860A (en) * 1962-02-08 1965-05-05 Pfizer & Co C N,n-disubstituted sulfamylureas and compositions thereof
US3245982A (en) 1962-03-27 1966-04-12 Pfizer & Co C Sulfamylsemicarbazides
DE1518541A1 (de) * 1965-03-16 1969-09-11 Boehringer Mannheim Gmbh Verfahren zur Herstellung von Sulfonylharnstoffen und Sulfonylsemicarbaziden
FR2339694A1 (fr) 1976-01-30 1977-08-26 Martin Usines Fonderie Arthur Machine a laver le linge comportant un dispositif de sechage par ventilation d'air chaud
CH649081A5 (de) * 1982-01-12 1985-04-30 Ciba Geigy Ag Triaza-verbindungen.

Also Published As

Publication number Publication date
PT99435B (pt) 1999-04-30
US5288757A (en) 1994-02-22
GR3020355T3 (en) 1996-09-30
PH30665A (en) 1997-09-16
EP0556322A1 (en) 1993-08-25
DK0556322T3 (da) 1996-10-14
AU657928B2 (en) 1995-03-30
IE75379B1 (en) 1997-09-10
MX9101958A (es) 1992-07-08
DE69120287D1 (en) 1996-07-18
DE69120287T2 (de) 1996-10-10
JP3256541B2 (ja) 2002-02-12
NZ240481A (en) 1994-06-27
AU8959791A (en) 1992-06-11
WO1992008694A1 (en) 1992-05-29
ES2088128T3 (es) 1996-08-01
IE913874A1 (en) 1992-05-20
CA2094806C (en) 2004-11-02
ATE139226T1 (de) 1996-06-15
JP2001026574A (ja) 2001-01-30
EP0556322B1 (en) 1996-06-12
JPH06501707A (ja) 1994-02-24
US5214206A (en) 1993-05-25
CA2094806A1 (en) 1992-05-08

Similar Documents

Publication Publication Date Title
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
ATE255589T1 (de) Kristallin form i von clarithromycin
PT99435A (pt) Processo para a preparacao de derivados de amino-sulfonil-ureia e de composicoes farmaceuticas que os contem
PT98905A (pt) Processo para a preparacao de mono-hidrato de furoato de mometasona,e de composicoes farmaceuticas que o contem
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BR0009651A (pt) Composto, processo para a preparação de um composto, composição farmacêutica, uso de um composto, e, método para tratar artrite reumatóide e uma doença obstrutiva das vias aéreas
EE03253B1 (et) (R)-5-karbamoüül-8-fluoro-3-N,N-diasendatud-amino-3,4-dihüdro-2H-1-bensopüraani d, nende valmistamise protsess ja neid sisaldavad ravimkoostised
BR9813028A (pt) Agonistas de prostaglandina e seu uso para tratar distúrbios nos ossos
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
PT89502A (pt) Processo para a preparacao de derivados de 2-(2-hidroxi-3-fenoxi-metilo e de composicoes farmaceuticas que os contem
PT92497A (pt) Processo para a preparacao de derivados de ureia de dipeptideos inibidores de enzimas, e de composicoes farmaceuticas que os contem
BR0014767A (pt) Fibras de sementes de plantas e uso
BRPI0111116B8 (pt) imitadores de trombopoietina
PT90764A (pt) Processo para a preparacaode um produto farmaceutico compreendendo um estrogenio e um anti-estrigenio e de composicoes farmaceuticas que os contem
PT83961B (pt) Processo para a preparacao de derivados da pirazolina e de composicoes insecticidas e acaricidas que os contem
PT96304A (pt) Processo para a preparacao de novos derivados de cromano e de tiocromano e de composicoes farmaceuticas que os contem
BR9811099A (pt) Inibidores de urocinase
PT91351A (pt) Processo para a preparacao de derivados de alcoxi-4-(1h)-piridona e de composicoes farmaceuticas que os contem
BR9910329A (pt) Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto
IT1265101B1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
PT98108A (pt) Processo para a preparacao de n-oxidos de piridina 2,4- e 2,5-dissubstituidos, e de composicoes farmaceuticas que os contem
BR9201253A (pt) Composto,processo para a sua preparacao,agente diagnostico ou terapeutico e aplicacao do mencionado composto
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
PT1194415E (pt) Novos derivados da piperazinil-alquil-tiopirimidina composicoes farmaceuticas que os contem e um processo de preparacao da substancia activa
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920814

FG3A Patent granted, date of granting

Effective date: 19990119

MM3A Annulment or lapse

Effective date: 20060719